# Agnès Viale

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/agnes-viale/

## Facts

| Field | Value |
| --- | --- |
| Citations | 68,338 |
| Field | Cancer Genomics and Diagnostics |
| h-index | 98 |
| i10-index | 180 |
| Last Known Institution | Kraft Heinz (United States) |
| OpenAlex ID | https://openalex.org/A5065067520 |
| ORCID iD | https://orcid.org/0000-0001-8644-9017 |
| Works | 553 |

## Researcher papers

- [<i>MET</i> amplification occurs with or without <i>T790M</i> mutations in <i>EGFR</i> mutant lung tumors with acquired resistance to gefitinib or erlotinib](https://scholariq.org/papers/i-met-i-amplification-occurs-with-or-without-i-t790m-i-mutations-in-i-egfr-i/)
- [Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study](https://scholariq.org/papers/gene-expression-based-survival-prediction-in-lung-adenocarcinoma-a-multi-site/)
- [The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers](https://scholariq.org/papers/the-genomic-landscape-of-endocrine-resistant-advanced-breast-cancers/)
- [Molecular International Prognostic Scoring System for Myelodysplastic Syndromes](https://scholariq.org/papers/molecular-international-prognostic-scoring-system-for-myelodysplastic-syndromes/)
- [<sup>V600E</sup> BRAF is associated with disabled feedback inhibition of RAF–MEK signaling and elevated transcriptional output of the pathway](https://scholariq.org/papers/sup-v600e-sup-braf-is-associated-with-disabled-feedback-inhibition-of-raf-mek/)
- [The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective manner](https://scholariq.org/papers/the-raf-inhibitor-plx4032-inhibits-erk-signaling-and-tumor-cell-proliferation-in/)
- [Relief of Feedback Inhibition of <i>HER3</i> Transcription by RAF and MEK Inhibitors Attenuates Their Antitumor Effects in <i>BRAF</i> -Mutant Thyroid Carcinomas](https://scholariq.org/papers/relief-of-feedback-inhibition-of-i-her3-i-transcription-by-raf-and-mek/)

## Researcher topics

- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Genetic factors in colorectal cancer](https://scholariq.org/topics/genetic-factors-in-colorectal-cancer/)
- [Melanoma and MAPK Pathways](https://scholariq.org/topics/melanoma-and-mapk-pathways/)
- [Epigenetics and DNA Methylation](https://scholariq.org/topics/epigenetics-and-dna-methylation/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [Kraft Heinz (United States)](https://scholariq.org/institutions/kraft-heinz-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.